Frontiers Lu-177-PSMA dosimetry for kidneys and tumors based on SPECT images at two imaging time points

Development of 177Lu-scFvD2B as a Potential Immunotheranostic

Frontiers Towards Routine Clinical Use of Dosimetry in [177Lu]Lu

Molecules, Free Full-Text

Optimizing treatment activities for [ 225 Ac]Ac-and [ 177 Lu]Lu

SNMMI 2023: Tumour-to-Kidney Ratio on Pre-Therapeutic PSMA-PET-CT

Frontiers 177Lu-labeled PSMA targeting therapeutic with

Frontiers Lu-177-PSMA dosimetry for kidneys and tumors based on

Theranostics and artificial intelligence: new frontiers in

PDF) Lu-177-PSMA dosimetry for kidneys and tumors based on SPECT

Preclinical Dosimetry, Imaging, and Targeted Radionuclide Therapy

Frontiers Towards Routine Clinical Use of Dosimetry in [177Lu]Lu

SPECT reconstructions of the 177 Lu distribution in two patients